Table 6.

Ratio of naive to activated CD4 T cells at different time points of the Eastern Cooperative Oncology Group trial

Time pointsN6-150Median6-151
Baseline 444 0.80  
2 months 370 1.33 
2 years 162 1.82  
Relapse 96 1.12 
Time pointsN6-150Median6-151
Baseline 444 0.80  
2 months 370 1.33 
2 years 162 1.82  
Relapse 96 1.12 
F6-150

Numbers of myeloma patients studied at each time point.

F6-151

Median value of the ratio of naive to activated CD4+ T cells.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal